{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:27:43Z","timestamp":1679866063907},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Human leukocyte antigen (HLA) and immunity are related. Uveitis is also closely related to immunity. For example, the common presence of human leukocyte antigen (HLA)-DRB1*04 in the immune response is well known. The aim of this study was to investigate the relationship between visual prognosis and various HLA alleles before and after therapy in patients with unclassifiable uveitis, excluding those with Vogt-Koyanagi-Harada (VKH) disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective case series included 42 eyes from 22 consecutive patients with unclassifiable uveitis, excluding those with VKH disease. Visual acuity (VA), sex, refractive error, central retinal thickness (CRT), central choroidal thickness (CCT), and duration from onset to treatment were measured at initial and 6-month visits. Mean values of parameters were compared at each visit. Genotyping was performed by polymerase chain reaction amplification with sequence-specific primers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DRB1*04 showed a dominant change. No significant difference was observed in the other alleles. In DRB1*04, The mean differences in initial CCT, 6-month CCT, and 6-month VA showed statistically significant difference was found in best-corrected visual acuity (BCVA) between DRB1*04+ and DRB1*04\u2212 at the first visit. BCVA values at baseline and at the final visit were 0.13\u2009\u00b1\u20090.29 and 0.20\u2009\u00b1\u20090.36 in the DRB1*04+ and 0.00045\u2009\u00b1\u20090.20 and\u2009\u2212\u20090.058\u2009\u00b1\u20090.11 in the DRB1*04\u2212 groups(<jats:italic>p<\/jats:italic>\u2009=\u20090.00465). Central Choroidal Thickness (CCT) values pretreatment and at the final visit after treatment were (pretreatment:361.00\u2009\u00b1\u2009361.0\u2009\u03bcm,after treatment: 286.00\u2009\u00b1\u2009106.53\u2009\u03bcm,<jats:italic>p<\/jats:italic>\u2009=\u20090.0174) in the DRB1*04+ group, and (pretreatment:281.3\u2009\u00b1\u2009139.68\u2009\u03bcm,after treatment:223.85\u2009\u00b1\u200999.034\u2009\u03bcm,<jats:italic>p<\/jats:italic>\u2009=\u20090.0426) in the DRB1*04\u2212 group, respectively, indicating changes between baseline and the final visit. CCT was significantly greater in the DRB1*04+ group at both the initial visit and at 6\u2009months. Multivariate analysis showed a significant difference between the presence or absence of DRB1*04 and sex.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HLA-DRB1*04 allele may affect visual prognosis and CCT in unclassifiable uveitis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12886-021-02222-9","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T16:02:27Z","timestamp":1640707347000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Visual outcomes and choroidal thickness associated with human leukocyte antigen DRB1*04 in unclassifiable uveitis in Japanese patients"],"prefix":"10.1186","volume":"21","author":[{"given":"Norihiko","family":"Misawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeya","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"issue":"3","key":"2222_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ophtha.2003.06.014","volume":"111","author":"DC Gritz","year":"2004","unstructured":"Gritz DC, Wong IG. Incidence and prevalence of uveitis in northern California; the northern California epidemiology of uveitis study. Ophthalmology. 2004;111(3):491\u2013500 discussion 500.","journal-title":"Ophthalmology"},{"issue":"1","key":"2222_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10384-006-0383-4","volume":"51","author":"H Goto","year":"2007","unstructured":"Goto H, Mochizuki M, Yamaki K, Kotake S, Usui M, Ohno S. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51(1):41\u20134.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"2222_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12886-018-0871-6","volume":"18","author":"S Shirahama","year":"2018","unstructured":"Shirahama S, Kaburaki T, Nakahara H, Tanaka R, Takamoto M, Fujino Y, et al. Epidemiology of uveitis (2013-2015) and changes in the patterns of uveitis (2004-2015) in the Central Tokyo area: a retrospective study. BMC Ophthalmol. 2018;18(1):189.","journal-title":"BMC Ophthalmol"},{"key":"2222_CR4","doi-asserted-by":"crossref","unstructured":"Kunimi K, Usui Y, Tsubota K, Mitsuhashi R, Umazume A, Kezuka T, et al. Changes in etiology of uveitis in a single Center in Japan. Ocul Immunol Inflamm. 2020:1\u20136.","DOI":"10.1080\/09273948.2020.1791346"},{"issue":"13","key":"2222_CR5","first-page":"3131","volume":"32","author":"Nussenblatt RB: Proctor Lecture","year":"1991","unstructured":"Nussenblatt RB: Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Vis Sci. 1991;32(13):3131\u201341.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8781","key":"2222_CR6","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/0140-6736(91)92310-X","volume":"338","author":"S Lightman","year":"1991","unstructured":"Lightman S. Uveitis: management. Lancet. 1991;338(8781):1501\u20134.","journal-title":"Lancet"},{"issue":"8781","key":"2222_CR7","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/0140-6736(91)92309-P","volume":"338","author":"JV Forrester","year":"1991","unstructured":"Forrester JV. Uveitis: pathogenesis. Lancet. 1991;338(8781):1498\u2013501.","journal-title":"Lancet"},{"key":"2222_CR8","doi-asserted-by":"publisher","first-page":"107853","DOI":"10.1016\/j.exer.2019.107853","volume":"190","author":"S Hou","year":"2020","unstructured":"Hou S, Li N, Liao X, Kijlstra A, Yang P. Uveitis genetics. Exp Eye Res. 2020;190:107853.","journal-title":"Exp Eye Res"},{"issue":"9","key":"2222_CR9","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2169\/internalmedicine.2035-18","volume":"58","author":"Y Kirino","year":"2019","unstructured":"Kirino Y, Nakajima H. Clinical and genetic aspects of Beh\u00e7et's disease in Japan. Intern Med. 2019;58(9):1199\u2013207.","journal-title":"Intern Med"},{"key":"2222_CR10","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","volume":"10","author":"P Leccese","year":"2019","unstructured":"Leccese P, Alpsoy E. Beh\u00e7et's disease: an overview of Etiopathogenesis. Front Immunol. 2019;10:1067.","journal-title":"Front Immunol"},{"issue":"8359","key":"2222_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(83)90628-1","volume":"322","author":"T Hanafusa","year":"1983","unstructured":"Hanafusa T, Chiovato L, Doniach D, Pujol-Borrell R, Russell RCG, Bottazzo GF. Aberrant expression of hla-dr antigen on thyrocytes in graves' disease: relevance for autoimmunity. Lancet. 1983;322(8359):1111\u20135.","journal-title":"Lancet"},{"issue":"10","key":"2222_CR12","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/art.40917","volume":"71","author":"M Asquith","year":"2019","unstructured":"Asquith M, Sternes PR, Costello M-E, Karstens L, Diamond S, Martin TM, et al. HLA alleles associated with risk of Ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 2019;71(10):1642\u201350.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"2222_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.2008.01167.x","volume":"73","author":"S Caillat-Zucman","year":"2009","unstructured":"Caillat-Zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens. 2009;73(1):1\u20138.","journal-title":"Tissue Antigens"},{"key":"2222_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ajo.2018.06.023","volume":"194","author":"MWM Wintergerst","year":"2018","unstructured":"Wintergerst MWM, Pfau M, M\u00fcller PL, Berger M, de Sisternes L, Holz FG, et al. Optical coherence tomography angiography in intermediate uveitis. Am J Ophthalmol. 2018;194:35\u201345.","journal-title":"Am J Ophthalmol"},{"key":"2222_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1\u201355.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"2222_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/IAE.0000000000002177","volume":"39","author":"KA Raafat","year":"2019","unstructured":"Raafat KA, Allam R, Medhat BM. Optical coherence tomography angiography findings in patients with nonocular beh\u00e7et disease. Retina. 2019;39(8):1607\u201312.","journal-title":"Retina"},{"issue":"2","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/bjophthalmol-2016-309499","volume":"102","author":"P Yang","year":"2018","unstructured":"Yang P, Wan W, Du L, Zhou Q, Qi J, Liang L, et al. Clinical features of HLA-B27-positive acute anterior uveitis with or without ankylosing spondylitis in a Chinese cohort. Br J Ophthalmol. 2018;102(2):215\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0161-6420(90)32446-6","volume":"97","author":"JL Davis","year":"1990","unstructured":"Davis JL, Mittal KK, Freidlin V, Mellow SR, Optican DC, Palestine AG, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic Ophthalmia. Ophthalmology. 1990;97(9):1137\u201342.","journal-title":"Ophthalmology"},{"issue":"1","key":"2222_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12886-019-1227-6","volume":"19","author":"N Misawa","year":"2019","unstructured":"Misawa N, Tagami M, Kohno T, Honda S. Correlation between visual acuity and human leukocyte antigen DRB1*04 in patients with Vogt-Koyanagi-Harada disease. BMC Ophthalmol. 2019;19(1):214.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"2222_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647\u201352.","journal-title":"Am J Ophthalmol"},{"issue":"8697","key":"2222_CR21","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Beh\u00e7et's disease","year":"1990","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International study Group for Beh\u00e7et's disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"3","key":"2222_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273940902818861","volume":"17","author":"CP Herbort","year":"2009","unstructured":"Herbort CP, Rao NA, Mochizuki M. International criteria for the diagnosis of ocular sarcoidosis: results of the first international workshop on ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17(3):160\u20139.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"2222_CR23","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.4049\/jimmunol.151.12.7284","volume":"151","author":"IC Lepoole","year":"1993","unstructured":"Lepoole IC, Mutis T, RMJGJ V, Westerhof W, Ottenhoff T, RRP D, et al. A novel, antigen-presenting function of melanocytes and its possible relationship to Hypopigmentary disorders. J Immunol. 1993;151(12):7284\u201392.","journal-title":"J Immunol"},{"issue":"7","key":"2222_CR24","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1167\/iovs.04-1273","volume":"46","author":"FM Damico","year":"2005","unstructured":"Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci. 2005;46(7):2465\u201371.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2222_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0161-6420(83)34602-9","volume":"90","author":"FA Jakobiec","year":"1983","unstructured":"Jakobiec FA, Marboe CC, Knowles DM, Iwamoto T, Harrison W, Chang S, et al. Human sympathetic Ophthalmia. Ophthalmology. 1983;90(1):76\u201395.","journal-title":"Ophthalmology"},{"key":"2222_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13023-016-0412-4","volume":"11","author":"MM Lavezzo","year":"2016","unstructured":"Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2222_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1136\/bjo.2007.129742","volume":"92","author":"MK Ezzat","year":"2008","unstructured":"Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol. 2008;92(7):976\u201380.","journal-title":"Br J Ophthalmol"},{"issue":"24","key":"2222_CR28","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1073\/pnas.86.24.10049","volume":"86","author":"BP Wordsworth","year":"1989","unstructured":"Wordsworth BP, Lanchbury JS, Sakkas LI, Welsh KI, Panayi GS, Bell JI. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci. 1989;86(24):10049\u201353.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"2222_CR29","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/MIB.0000000000001282","volume":"23","author":"A Irie","year":"2017","unstructured":"Irie A, Imamura T, Michibata Y, Kubo T, Takeda N, Shibuya I, et al. Accumulation of HLA-DR4 in colonic epithelial cells causes severe colitis in homozygous HLA-DR4 transgenic mice. Inflamm Bowel Dis. 2017;23(12):2121\u201333.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2222_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/tan.12536","volume":"85","author":"N Ikeda","year":"2015","unstructured":"Ikeda N, Kojima H, Nishikawa M, Hayashi K, Futagami T, Tsujino T, et al. Determination of HLA-A, \u2212C, \u2212B, \u2212DRB1 allele and haplotype frequency in Japanese population based on family study. Tissue Antigens. 2015;85(4):252\u20139.","journal-title":"Tissue Antigens"},{"issue":"5","key":"2222_CR31","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1167\/iovs.18-26086","volume":"60","author":"J Ye","year":"2019","unstructured":"Ye J, Shen M, Huang S, Fan Y, Yao A, Pan C, et al. Visual acuity in pathological myopia is correlated with the photoreceptor Myoid and ellipsoid zone thickness and affected by choroid thickness. Invest Ophthalmol Vis Sci. 2019;60(5):1714\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2222_CR32","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nri1708","volume":"5","author":"W Reith","year":"2005","unstructured":"Reith W, LeibundGut-Landmann S, Waldburger JM. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5(10):793\u2013806.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2222_CR33","first-page":"561","volume":"9","author":"M Zhao","year":"2016","unstructured":"Zhao M, Yang XF, Jiao X, Lim A, Ren XT, Snellingen T, et al. The diurnal variation pattern of choroidal thickness in macular region of young healthy female individuals using spectral domain optical coherence tomography. Int J Ophthalmol. 2016;9(4):561\u20136.","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"2222_CR34","doi-asserted-by":"publisher","first-page":"e585","DOI":"10.1111\/aos.12631","volume":"93","author":"P Gupta","year":"2015","unstructured":"Gupta P, Saw SM, Cheung CY, Girard MJ, Mari JM, Bhargava M, et al. Choroidal thickness and high myopia: a case-control study of young Chinese men in Singapore. Acta Ophthalmol. 2015;93(7):e585\u201392.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"2222_CR35","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajo.2015.07.027","volume":"160","author":"R Bafiq","year":"2015","unstructured":"Bafiq R, Mathew R, Pearce E, Abdel-Hey A, Richardson M, Bailey T, et al. Age, sex, and ethnic variations in inner and outer retinal and Choroidal thickness on spectral-domain optical coherence tomography. Am J Ophthalmol. 2015;160(5):1034\u20131043.e1031 Ooto S, Hangai M, Yoshimura N. effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography. Curr Eye Res 2015;40:213\u201325.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2222_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/02713683.2014.952828","volume":"40","author":"S Ooto","year":"2015","unstructured":"Ooto S, Hangai M, Yoshimura N. Effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography. Curr Eye Res. 2015;40(2):213\u201325.","journal-title":"Curr Eye Res"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02222-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02222-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T19:42:19Z","timestamp":1674243739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02222-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02222-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"4 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the Institutional and\/or National Research Committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.Approval for this study was obtained prior to the start of the study from the institutional review board at Osaka City University, Japan (IRB-4239). Written informed consent for the storage of patient information in the hospital database and use in the research was provided by all patients enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}